Notice of Availability of Administrative Supplements for Equipment Purchases for NIGMS Awardees

Notice Number: NOT-GM-19-013

Key Dates
Release Date: January 7, 2019

Related Announcements

Issued by
National Institute of General Medical Sciences (NIGMS)


The National Institute of General Medical Sciences (NIGMS) announces the availability of funds for Administrative Supplements to NIGMS-funded R01, R35, and R37 awards. These funds are intended for the purchase of single pieces of equipment with requested direct costs up to $250,000.  Equipment in this price range is often difficult to purchase under the parent grant. Two NIGMS grantees at the same institution with similar equipment needs are encouraged to submit separate requests (with a combined budget of not more than $250,000 direct costs) that cross-reference each other. It is expected that the amount of funds requested for such joint purchases will reflect the actual proportion of the time that the shared equipment would be used by each PD/PI.    
The requested supplemental budget cannot exceed the total year direct cost amount of the parent award. PD/PIs may not request future year funds.
Applications should include price quotes or other documentation, in addition to a strong scientific justification for the requested equipment supplement.  As part of the budgetary justification, a statement regarding the expenditure of currently available unobligated grant funds should be included.
NIGMS encourages requests that reflect institutional commitment. Institutional commitment will be taken into consideration when making funding decisions.
Applications must be submitted to PA-18-591 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)" by March 15, 2019. Electronic submissions are strongly preferred for this funding opportunity.
Eligible investigators are strongly encouraged to discuss potential requests with their Program Directors before submitting applications.


Please direct all inquiries to:

Dorit Zuk, PhD
National Institute of General Medical Sciences (NIGMS)